PLK1 and neoplasm: The novelty of our study lies in the fact we first demonstrate that PLK1 promotes M2 polarization and inhibits antigen presentation pathway by down-regulating MHC-II in professional antigen-presenting cells, which is the key molecule responsible for processing and presentation of tumor-specific neoantigens.